PRZOOM - /newswire/ -
Hoboken, NJ, United States, 2021/01/15 - Open access journal Clinical and Translational Allergy (CTA) published by Wiley as of January 2021 - EAACI.org / Wiley.com. NYSE: JWa, JWb
The European Academy of Allergy and Clinical Immunology (EAACI) and John Wiley & Sons Inc., a global leader in research and education, have expanded their publishing partnership to include EAACI’s official open access journal Clinical and Translational Allergy (CTA) alongside their other publications, Allergy and Pediatric Allergy and Clinical Immunology, as of January 2021.
CTA is a fully open access journal, edited by Prof. Jean Bousquet and Dr. Clive Grattan, and provides a dissemination of allergy research and reviews, as well as EAACI position papers, task force reports, and guidelines for an international scientific audience.
“We are delighted to extend our collaboration with Wiley to include CTA in 2021. Having all three journals under the same publishing umbrella will allow them to benefit from Wiley's extensive expertise in the publishing process, while at the same time keeping up the high quality of EAACI's scientific content, including the most relevant progress and updates in the field." Tomàs Chivato, EAACI VP Science; Jean Bousquet, CTA Editor-in-Chief; Clive Grattan, CTA Editor-in-Chief.
“We are very pleased to add another open access title to our growing health sciences portfolio,” said Martin Vinding, Senior Editorial Director, at Wiley. “Authors publishing in CTA will benefit from our open access experience and many funding agreements that help authors pay for publication.”
More information is available on the CTA journal site, at Wiley Open Access and Wiley Author Services.
The European Academy of Allergy and Clinical Immunology (EAACI.org) is an association of clinicians, researchers and allied health professionals, dedicated to improving the health of people affected by allergic diseases. With more than 13,000 members from 124 countries and over 70 National Allergy Societies, EAACI is the primary source of expertise in Europe for all aspects of allergy.
Wiley (wiley.com) drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders.